Table 1. Baseline Demographic Variables.
| Women | Men | |||
|---|---|---|---|---|
| Nondiabetic (N=21) |
T2D (N=15) |
Nondiabetic N=13 |
T2D N=14 |
|
| Age (yrs) | 42.8±5.1 | 45.2±4.6 | 46.0±6.2 | 45.9±6.8 |
| BMI (kg/m2) | 29.1±3.0 | 30.9±3.8 | 28.5±0.9 | 30.6±4.6 |
| Physical Activity (MET/hrs) | 243±37 | 230±42 | 251±58 | 261±52 |
| Duration of disease (yrs) | 3.5±3.3@ | 2.8±2.3@ | ||
| Diabetes Medications (metformin and/or sulfonylureas) | 6 | 4 | ||
| Statins | 1 | 2 | 2 | 2 |
| HbA1C (%) | 5.4±0.3 | 6.6±0.7*@ | 5.5±0.5 | 6.7±1.4*@ |
| Glucose (mg/dL) | 87.2±9.4 | 122.7±32.9*@ | 96.6±21.1 | 124.0±66.4*@ |
| Estradiol pg/mL | 80.4±59.1 | 72.0±50.6 | ||
| Adiponectin ug/mL | 12.0±5.3 | 9.3±6.6* | 9.0±3.8 | 6.0±3.3† |
| CRP (mg/dL) | 2.8±2.9 | 4.1±4.2*@ | 1.5±0.4 | 3.7±3.9*@ |
| IL-6 (pg/mL) | 1.3±0.9 | 2.4±1.5*@ | 0.9±0.2 | 2.8±3.2*@ |
| Cholesterol (mg/dL) | 183±30 | 171±27 | 178±32 | 170±30 |
| LDL (mg/dL) | 106±31 | 101±27 | 104.9±29 | 94.5±27 |
| HDL (mg/dL) | 55±13 | 46±10* | 42.6±13 | 42.4±8 |
| Insulin Sensitivity (MGIR) wt | 7.9±3.7 | 3.8±1.4* | 4.8±2.0 | 3.8±2.4† |
| Insulin Sensitivity (MGIR) BMI | 328.0±150.1 | 167.3±62.1*@ | 210.3±75.7 | 166.7±99.4*@ |
Abbreviations: T2D, Type 2 Diabetes Mellitus; BMI, Body Mass Index; LOPAR, Low level Activity Recall; MET, Metabolic equivalent; HbA1C, glycosylated hemoglobin; CRP, C-reactive protein; IL-6, interleukin-6; MGIR, mean glucose infusion rate,
*
0.05 difference between people with diabetes and non-diabetic people by sex
†
tendency towards a difference between people with diabetes and non-diabetic people by sex (P<0.10)
@
0.05 difference between all people with diabetes and all nondiabetic people